¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"asymptomatic persistent proteinuria"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • simple proteinuria
    ´Ü¼ø´Ü¹é´¢
  • chronic persistent hepatitis
    ¸¸¼ºÁö¼Ó°£¿°
  • ostium primum persistent
    ù°±¸¸ÛÁö¼Ó(Áõ), ÀÏÂ÷°ø°³Á¸(Áõ)
  • persistent
    Áö¼Ó-, ÀÜ·ù-
  • persistent acantholytic dermatosis
    Áö¼Ó°¡½Ã¼¼Æ÷ÇØ¸®ÇǺκ´
  • persistent cathode ray tube
    Áö¼ÓÀ½±Ø¼±°ü
  • persistent cloaca
    ¹è¼³°­Á¸¼ÓÁõ
  • persistent fetal hemoglobin
    Áö¼ÓžÆÇ÷»ö¼Ò
  • persistent hyaloid artery
    ÀÜ·ùÀ¯¸®Ã¼µ¿¸Æ
  • persistent infection
    Áö¼Ó°¨¿°
  • persistent light reaction
    Áö¼Ó±¤¹ÝÀÀ
  • persistent palmoplantar pustulosis
    Áö¼Ó¼Õ¹ß¹Ù´Ú°í¸§¹°ÁýÁõ, Áö¼Ó¼Õ¹ß¹Ù´Ú³óÆ÷Áõ
  • persistent superficial dermatitis
    Áö¼ÓÇ¥ÀçÇǺο°
  • persistent tremor
    Áö¼Ó¶³¸²
  • persistent vegetative state
    Áö¼Ó½Ä¹°»óÅÂ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • simple proteinuria
    ´Ü¼ø´Ü¹é´¢
  • transient proteinuria
    ÀϽÃÀû´Ü¹é´¢
  • persistent hyaloid artery
    ÀÜ·ùÀ¯¸®Ã¼µ¿¸Æ
  • chronic persistent hepatitis
    ¸¸¼ºÁö¼Ó°£¿°
  • persistent cloaca
    ¹è¼³°­Á¸¼ÓÁõ
  • persistent acantholytic dermatosis
    Áö¼Ó°¡½Ã¼¼Æ÷ÇØ¸®ÇǺκ´
  • persistent superficial dermatitis
    Áö¼ÓÇ¥ÀçÇǺο°
  • persistent fetal hemoglobin
    Áö¼ÓžÆÇ÷»ö¼Ò
  • persistent infection
    Áö¼Ó°¨¿°
  • persistent o. primum ostium
    ù°±¸¸ÛÁö¼Ó(Áõ), ÀÏÂ÷°ø°³Á¸(Áõ)
  • persistent o. secundum ostium
    µÑ°±¸¸ÛÁö¼Ó(Áõ), ÀÌÂ÷°ø°³Á¸(Áõ)
  • persistent
    Áö¼Ó-, ÀÜ·ù-
  • persistent tremor
    Áö¼Ó¶³¸²
  • persistent vomiting
    Áö¼Ó±¸Åä
  • persistent cathode ray tube
    Áö¼ÓÀ½±Ø¼±°ü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • persistent generalized lymphadenopathy
    Áö¼Ó¼º Àü½Å¼º ¸²ÇÁ¼±Áõ
  • persistent hyaloid artery
    À¯¸®Ã¼µ¿¸ÆÀÜ·ù
  • persistent hyperplastic vitreous
    ÀÏÂ÷À¯¸®Ã¼Áõ½ÄÁõ
  • persistent infection
    Áö¼Ó°¨¿°
  • persistent light reaction
    Áö¼Ó¼º ±¤¹ÝÀÀ
  • persistent ostium primum
    ÀÏÂ÷°ø°³Á¸(Áõ) (ìéó­ÍîËÒðíñø).
  • persistent ostium secundum
    ÀÌÂ÷°ø°³Á¸(Áõ)(ì£ó­ÍîËÒðíñø).
  • persistent pain
    Áö¼ÓÅë(ò¥áÙ÷Ô).
  • persistent palmoplantar pustulosis
    Áö¼Ó¼º ¼Õ¹ß¹Ù´Ú ³óÆ÷Áõ
  • persistent pupillary membrane
    µ¿°ø¸·Á¸¼Ó
  • persistent silent infection
    Áö¼Ó¼º Àẹ°¨¿°.
  • persistent somatoform pain disorder
    Áö¼Ó¼º ½ÅüÇü µ¿ÅëÀå¾Ö(º´)
  • persistent superficial dermatitis
    Áö¼Ó¼º Ç¥À缺 ÇǺο°
  • persistent tremor
    Áö¼Ó¼º ÁøÀü(ò¥áÙàõòèïµ).
  • persistent truncus arteriosus
    µ¿¸Æ°£Á¸¼Ó(Áõ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • overflow proteinuria
    °úµµÀÏÃâ<--ÀÏ·ù>´Ü¹é´¢(Áõ)
  • palpatory proteinuria
    ÃËÁø¼º ´Ü¹é´¢(õºòààõÓ±ÛÜèñ).
  • proteinuria
    ´Ü¹é´¢(Ó±ÛÜèñ).
  • proteinuria
    ´Ü¹é´¢(Ó±ÛÜèñ)
  • proteinuria
    ´Ü¹é´¢
  • proteinuria testing
    ´Ü¹é´¢½ÃÇè
  • residual proteinuria
    ÀÜÀç(¼º) ´Ü¹é´¢(íÑî¤àõÓ±ÛÜèñ).
  • residual proteinuria
    ÀÜÀç(¼º) ´Ü¹é´¢(íÑî¤àõÓ±ÛÜèñ)
  • acral persistent papular mucinosis
    ¸»´Ü Áö¼Ó¼º ±¸Áø¼º Á¡¾×Áõ
  • chronic persistent hepatitis
    ¸¸¼º Áö¼Ó¼º °£¿°
  • growing teeth from persistent pulp
    »ó»ýÄ¡ (ßÈßæöÍ).
  • hepatitis,chronic persistent
    ¸¸¼ºÁö¼Ó¼º(Ø·àõò¥áÙàõ)
  • infection, persistent
    Áö¼Ó°¨¿°
  • persistent Mullerian duct syndrome
  • persistent acantholytic dermatosis
    Áö¼Ó¼º ±Ø¼¼Æ÷ÇØ¸® ÇǺκ´
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
LMWP low molecular weight proteinuria
OP occipitoparietal; occipitoposterior; occiput posterior; octapeptide; olfactory peduncle; opening pre...
PGP phosphoglyceroyl phosphatase; postgamma proteinuria; prepaid group practice; progressive general par...
PP diphosphate group; emphysema [pink puffers]; near point of accommodation [Lat. punctum proximum]; pa...
PVC Premature Ventricular Contraction(s)
  = VEB
  ? Ix of Tx
  ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
AC asymptomatic carrier
CPH Chronic Persistent Hepatitis
PGL Persistent Generalised Lymphadenopathy
PHHI Persistent hyperinsulinaemic hypoglycaemia of infancy
PHPV Persistent Hyperplastic Primary Vitreous
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • persistent truncus arteriosus
    µ¿¸Æ°£ ÀÜÁ¸
  • persistent vegetative state
    Áö¼ÓÀû ½Ä¹° »óÅÂ
  • venae cava superior, persistent left
    Á¸¼Ó¼º Á»ó ´ëÁ¤¸Æ
    Á»ó ´ëÁ¤¸ÆÀÌ »ýÈÄ¿¡µµ Á¸¼ÓÇÏ´Â ¹ß»ýÇÐÀû ±âÇüÀ¸·Î¼­ º¸Åë Á½ɹ濡 Ç÷¾×À» ºñ¿î´Ù. ÁÂÀüÁÖ Á¤¸Æ »óºÎÀÇ Æó¼â Àå¾Ö¿¡ ÀÇÇÑ´Ù. ´Üµ¶¼º ±âÇüÀÇ °æ¿ìµµ ÀÖ°í Follot 4¡ÈÄ¿Í °°Àº ´Ù¸¥ ½ÉÇ÷°ü Àå¾Ö¸¦ ¼ö¹ÝÇÏ´Â °æ¿ìµµ ÀÖ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 2
persistent foetal circulation syndrome <syndrome> A syndrome of persistent pulmonary hypertension in the newborn infant, without demonstrable cardiac disease. It is characterised by cyanosis and acidosis, severe pulmonary vasoconstriction, hypertrophy of pulmonary arterial muscle, and elevated pulmonary vascular resistance, with resultant right-to-left shunting of blood through a patent ductus arteriosus and at times a patent foramen ovale.
(12 Dec 1998)
persistent generalised lymphadenopathy A syndrome characterised by reactive hyperplasia of lymph nodes (of at least one month's duration and at two different body sites, not including the inguinal area) in patients infected with the human immunodeficiency virus. The lymph node lesions progress from benign reactive hyperplasia through a stage of mixed follicular hyperplasia, to follicular involution with lymphocyte depletion. Many go on to a malignant non-Hodgkin's lymphoma.
(05 Mar 2000)
persistent mullerian duct syndrome <syndrome> Familial disorder with presence of fallopian tube, uterus, and testis in a male. Deficient mullerian inhibitory substance secondary to Sertoli cell defect.
Synonym: hernia uteri inguinale.
(05 Mar 2000)
persistent posterior hyperplastic primary vitreous A unilateral congenital anomaly in full-term infants; associated with a congenital retinal fold and a vitreous membranous stalk containing remnants of the hyaloid artery.
(05 Mar 2000)
persistent tremor A tremor that is constant, whether the subject is at rest or moving.
Synonym: continuous tremor.
(05 Mar 2000)
persistent truncus arteriosus A congenital cardiovascular deformity resulting from failure of development of the spiral septum and consisting of a common arterial trunk opening out of both ventricles, the pulmonary arteries being given off from the ascending common trunk.
(05 Mar 2000)
persistent vegetative state A persistent loss of upper cortical function that may follow acute (e.g., infections, toxins, trauma or vascular) events or chronic (e.g., degenerative) events. The patient is bedridden and nutritional support is completely passive, either parenteral or via nasogastric tube. The patient does not require respiratory support or circulatory assistance for survival and is in a state of chronic wakefulness without awareness which may be accompanied by spontaneous eye opening, grunts or screams, brief smiles, sporadic movement of facial muscles and limbs. While the eyes blink upon stimulation, they do not do so in response to visual threats. Some patients chew or clamp their teeth. Urinary and faecal incontinence is universal.
(12 Dec 1998)
chronic persistent hepatitis <pathology> A form of hepatitis usually caused by hepatitis C or B, that consists of mild persistent liver inflammation.
Often a mild elevation of the liver enzymes will be seen on liver profile or SMAC 25 assay. Liver biopsy indicates persistent hepatitis.
Incidence: 1 in 1,000.
(02 Jan 1998)
truncus arteriosus, persistent A congenital anomaly resulting from the failure of the aorticopulmonary system to develop and divide the truncus arteriosus into the aorta and the pulmonary trunk.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á